Winton Group LTD Enanta Pharmaceuticals Inc Transaction History

Winton Group LTD

$1.37 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$60.19 - $97.37 $932,282 - $1.51 Million	-15,489 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$41.02 - $58.65 $106,734 - $152,607	-2,602 Reduced 14.38%	15,489 $880,000
Q2 2021 Aug 10, 2021	SELL	$43.76 - $53.11 $71,460 - $86,728	-1,633 Reduced 8.28%	18,091 $796,000
Q1 2021 Jul 21, 2021	BUY	$41.69 - $54.95 $14,925 - $19,672	358 Added 1.85%	19,724 $973,000
Q4 2020 Feb 12, 2021	SELL	$41.16 - $47.47 $1.01 Million - $1.16 Million	-24,536 Reduced 55.89%	19,366 $815,000
Q3 2020 Oct 30, 2020	SELL	$43.36 - $53.53 $2.94 Million - $3.63 Million	-67,867 Reduced 60.72%	43,902 $2.01 Million
Q2 2020 Aug 05, 2020	SELL	$46.37 - $57.58 $635,408 - $789,018	-13,703 Reduced 10.92%	111,769 $5.61 Million
Q1 2020 May 11, 2020	SELL	$40.22 - $62.0 $503,071 - $775,496	-12,508 Reduced 9.07%	125,472 $6.45 Million
Q4 2019 Feb 13, 2020	BUY	$57.95 - $66.61 $7.78 Million - $8.95 Million	134,298 Added 3647.42%	137,980 $8.52 Million
Q3 2019 Nov 08, 2019	SELL	$60.08 - $88.17 $144,973 - $212,754	-2,413 Reduced 39.59%	3,682 $221,000
Q2 2019 Jul 08, 2019	BUY	$81.3 - $97.35 $125,120 - $149,821	1,539 Added 33.78%	6,095 $514,000
Q1 2019 May 13, 2019	BUY	$69.08 - $105.66 $72,810 - $111,365	1,054 Added 30.1%	4,556 $435,000
Q4 2018 Feb 05, 2019	SELL	$65.41 - $84.65 $76,856 - $99,463	-1,175 Reduced 25.12%	3,502 $248,000
Q3 2018 Nov 02, 2018	SELL	$85.46 - $126.37 $3.19 Million - $4.72 Million	-37,330 Reduced 88.87%	4,677 $0
Q2 2018 Aug 20, 2018	BUY	$81.85 - $120.51 $3.05 Million - $4.49 Million	37,231 Added 779.54%	42,007 $0
Q1 2018 May 21, 2018	BUY	$57.91 - $92.15 $276,578 - $440,108	4,776 New	4,776 $0

Others Institutions Holding ENTA

# of Institutions

Shares Held

21.2M

Call Options Held

10.4K

Put Options Held

2.3K

Farallon Capital Management LLC San Francisco, CA

2.1M
Shares

$21.7 Million
0.13% of portfolio
Vanguard Group Inc Valley Forge, PA

1.93M
Shares

$20.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$19.2 Million
0.0% of portfolio
Morgan Stanley New York, NY

1.46M
Shares

$15.1 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.25M
Shares

$13 Million
7.45% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $215M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account